These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 1554889)
1. Mammary carcinogenesis induced by N-methyl-N-nitrosourea (MNU) and medroxyprogesterone acetate (MPA) in BALB/c mice. Pazos P; Lanari C; Meiss R; Charreau EH; Pasqualini CD Breast Cancer Res Treat; 1992 Jan; 20(2):133-8. PubMed ID: 1554889 [TBL] [Abstract][Full Text] [Related]
2. Promoter effect of medroxyprogesterone acetate (MPA) in N-methyl-N-nitrosourea (MNU) induced mammary tumors in BALB/c mice. Pazos P; Lanari C; Elizalde P; Montecchia F; Charreau EH; Molinolo AA Carcinogenesis; 1998 Mar; 19(3):529-31. PubMed ID: 9525291 [TBL] [Abstract][Full Text] [Related]
3. Progesterone induction of mammary carcinomas in BALB/c female mice. Correlation between progestin dependence and morphology. Kordon EC; Molinolo AA; Pasqualini CD; Charreau EH; Pazos P; Dran G; Lanari C Breast Cancer Res Treat; 1993 Oct; 28(1):29-39. PubMed ID: 8123867 [TBL] [Abstract][Full Text] [Related]
4. Mammary adenocarcinomas induced by medroxyprogesterone acetate: hormone dependence and EGF receptors of BALB/c in vivo sublines. Lanari C; Kordon E; Molinolo A; Pasqualini CD; Charreau EH Int J Cancer; 1989 May; 43(5):845-50. PubMed ID: 2523869 [TBL] [Abstract][Full Text] [Related]
5. Hormone dependence of a mouse mammary tumor line induced in vivo by medroxyprogesterone acetate. Kordon E; Lanari C; Meiss R; Elizalde P; Charreau E; Dosne Pasqualini C Breast Cancer Res Treat; 1990 Nov; 17(1):33-43. PubMed ID: 2151368 [TBL] [Abstract][Full Text] [Related]
6. N-Ethyl-N-nitrosourea induces mammary cancers in the pituitary-isografted mouse which are histologically and genotypically distinct from those induced by N-methyl-N-nitrosourea. Swanson SM; Guzman RC; Tsukamoto T; Huang TT; Dougherty CD; Nandi S Cancer Lett; 1996 Apr; 102(1-2):159-65. PubMed ID: 8603364 [TBL] [Abstract][Full Text] [Related]
8. [Progestin-induced mammary adenocarcinomas in BALB/c mice. Progression from hormone-dependent to autonomous tumors]. Lanari C; Montecchia MF; Pazos P; Simian M; Vanzulli S; Lamb C; Molinolo AA Medicina (B Aires); 1997; 57 Suppl 2():55-69. PubMed ID: 9567344 [TBL] [Abstract][Full Text] [Related]
9. N-methyl-N-nitrosourea-induced rat mammary tumors. Hormone responsiveness but lack of spontaneous metastasis. Williams JC; Gusterson B; Humphreys J; Monaghan P; Coombes RC; Rudland P; Neville AM J Natl Cancer Inst; 1981 Jan; 66(1):147-55. PubMed ID: 6779042 [TBL] [Abstract][Full Text] [Related]
10. Mouse mammary tumors induced by medroxyprogesterone acetate: immunohistochemistry and hormonal receptors. Molinolo AA; Lanari C; Charreau EH; Sanjuan N; Pasqualini CD J Natl Cancer Inst; 1987 Dec; 79(6):1341-50. PubMed ID: 2826865 [TBL] [Abstract][Full Text] [Related]
11. Protective role of medroxyprogesterone acetate on N-methyl-N-nitrosourea-induced lymphomas in BALB/c female mice. Pazos P; Lanari C; Molinolo AA Leuk Res; 2001 Feb; 25(2):165-7. PubMed ID: 11166832 [TBL] [Abstract][Full Text] [Related]
12. Induction of mammary adenocarcinomas by medroxyprogesterone acetate in BALB/c female mice. Lanari C; Molinolo AA; Pasqualini CD Cancer Lett; 1986 Nov; 33(2):215-23. PubMed ID: 2947675 [TBL] [Abstract][Full Text] [Related]
13. Association of estrogen receptor-alpha and progesterone receptor A expression with hormonal mammary carcinogenesis: role of the host microenvironment. Montero Girard G; Vanzulli SI; Cerliani JP; Bottino MC; Bolado J; Vela J; Becu-Villalobos D; Benavides F; Gutkind S; Patel V; Molinolo A; Lanari C Breast Cancer Res; 2007; 9(2):R22. PubMed ID: 17341305 [TBL] [Abstract][Full Text] [Related]
14. Reversal of estrogen-resistance in murine mammary adenocarcinomas. Montecchia MF; Molinolo A; Lanari C Breast Cancer Res Treat; 1999 Mar; 54(2):93-9. PubMed ID: 10424399 [TBL] [Abstract][Full Text] [Related]
15. Progesterone receptor antagonism inhibits progestogen-related carcinogenesis and suppresses tumor cell proliferation. Lee O; Choi MR; Christov K; Ivancic D; Khan SA Cancer Lett; 2016 Jul; 376(2):310-7. PubMed ID: 27080304 [TBL] [Abstract][Full Text] [Related]
16. Refractoriness to mammary carcinogenesis in the parous mouse is reversible by hormonal stimulation induced by pituitary isografts. Swanson SM; Guzman RC; Collins G; Tafoya P; Thordarson G; Talamantes F; Nandi S Cancer Lett; 1995 Apr; 90(2):171-81. PubMed ID: 7736453 [TBL] [Abstract][Full Text] [Related]
17. Growth and characterization of N-methyl-N-nitrosourea-induced mammary tumors in intact and ovariectomized rats. Thordarson G; Lee AV; McCarty M; Van Horn K; Chu O; Chou YC; Yang J; Guzman RC; Nandi S; Talamantes F Carcinogenesis; 2001 Dec; 22(12):2039-47. PubMed ID: 11751437 [TBL] [Abstract][Full Text] [Related]
18. Effect of carcinogen dose and age at administration on induction of mammary carcinogenesis by 1-methyl-1-nitrosourea. Thompson HJ; Adlakha H; Singh M Carcinogenesis; 1992 Sep; 13(9):1535-9. PubMed ID: 1394836 [TBL] [Abstract][Full Text] [Related]
19. Medroxyprogesterone acetate accelerates the development and increases the incidence of mouse mammary tumors induced by dimethylbenzanthracene. Aldaz CM; Liao QY; LaBate M; Johnston DA Carcinogenesis; 1996 Sep; 17(9):2069-72. PubMed ID: 8824536 [TBL] [Abstract][Full Text] [Related]
20. Phenotypic variability of chemically induced primary rat mammary tumors. Dolezalová V; Rejthar A; Sugár J; Tóth J; Vermousek I Neoplasma; 1989; 36(1):103-12. PubMed ID: 2495492 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]